Prevalence and antimicrobial susceptibilities of bacteria isolated from blood cultures of hospitalized patients in the United States in 2002

Karlowsky, James A; Jones, Mark E; Draghi, Deborah C; Thornsberry, Clyde; Sahm, Daniel F; Volturo, Gregory A

doi:10.1186/1476-0711-3-7

Annals of Clinical Microbiology and Antimicrobials

Table 2 In vitro antimicrobial susceptibility testing results for the most common gram-positive and gram-negative bacterial species or groups isolated from blood cultures of hospitalized patients in the United States in 2002

From: Prevalence and antimicrobial susceptibilities of bacteria isolated from blood cultures of hospitalized patients in the United States in 2002

Gram-positive bacteria	Antimicrobial	Total No.	% Susceptible
Oxacillin-susceptible CoNS^a	Amoxicillin-clavulanate	1,692	99.8
	Cefotaxime	962	99.7
	Ceftriaxone	228	98.7
	Cefuroxime	131	100
	Ciprofloxacin	1,724	82.1
	Clindamycin	2,290	91.2
	Erythromycin	2,241	59.2
	Gentamicin	1,789	95.7
	Levofloxacin	1,652	82.7
	Ofloxacin	172	72.7
	Penicillin	2,106	31.7
	Trimethoprim-sulfamethoxazole	2,099	89.2
	Vancomycin	2,273	100
Oxacillin-susceptible S. aureus	Amoxicillin-clavulanate	1,854	99.7
	Cefotaxime	823	99.6
	Ceftriaxone	602	99.8
	Cefuroxime	424	99.8
	Ciprofloxacin	3,383	88.5
	Clindamycin	5,707	93.3
	Erythromycin	5,707	69.1
	Gentamicin	4,904	97.9
	Levofloxacin	3,903	89.4
	Ofloxacin	811	84.0
	Penicillin	5,532	14.3
	Trimethoprim-sulfamethoxazole	4,660	97.8
	Vancomycin	5,565	100
E. faecalis	Erythromycin	787	13.2
	Levofloxacin	1,793	52.1
	Penicillin	2,372	97.1
	Vancomycin	3,400	95.4
E. faecium	Erythromycin	421	4.0
	Levofloxacin	758	11.3
	Penicillin	913	13.3
	Vancomycin	1,285	32.9
Viridans group streptococci	Cefotaxime	719	89.2
	Ceftriaxone	1,120	89.9
	Clindamycin	1,227	89.0
	Erythromycin	1,681	46.6
	Levofloxacin	661	90.6
	Penicillin	2,005	60.0
	Vancomycin	1,901	100
S. pneumoniae	Amoxicillin-clavulanate	141	97.2
	Cefotaxime	750	96.3
	Ceftriaxone	1,149	97.2
	Cefuroxime	223	70.9
	Clindamycin	634	95.1
	Erythromycin	1,023	75.2
	Levofloxacin	762	99.5
	Ofloxacin	196	95.4
	Penicillin	1,345	68.0
	Trimethoprim-sulfamethoxazole	675	66.8
	Vancomycin	1,190	100
Gram-negative bacteria	Antimicrobial	Total No.	% Susceptible
E coli	Amikacin	3,815	99.1
	Amoxicillin-clavulanate	1,417	79.9
	Ampicillin	5,192	52.2
	Cefazolin	5,167	87.5
	Cefepime	2,966	98.3
	Cefotaxime	2,967	97.7
	Ceftazidime	4,067	96.2
	Ceftriaxone	3,820	97.3
	Cephalothin	1,879	61.5
	Ciprofloxacin	4,633	86.7
	Gentamicin	5,171	92.8
	Levofloxacin	4,266	86.0
	Nitrofurantoin	1,356	97.5
	Ofloxacin	456	88.6
	Piperacillin-tazobactam	3,887	95.4
	Tobramycin	4,414	93.5
	Trimethoprim-sulfamethoxazole	5,108	74.8
K. pneumoniae	Amikacin	1,987	97.6
	Amoxicillin-clavulanate	867	86.7
	Cefazolin	2,576	86.3
	Cefepime	1,613	96.5
	Cefotaxime	1,502	93.5
	Ceftazidime	2,134	88.5
	Ceftriaxone	2,104	93.3
	Cephalothin	930	75.3
	Ciprofloxacin	2,370	90.3
	Gentamicin	2,686	91.1
	Levofloxacin	2,264	91.4
	Nitrofurantoin	835	55.0
	Ofloxacin	275	90.2
	Piperacillin-tazobactam	1,997	89.9
	Tobramycin	2,320	90.7
	Trimethoprim-sulfamethoxazole	2,625	87.2
P. aeruginosa	Amikacin	1,563	92.3
	Cefepime	1,450	76.7
	Ceftazidime	1,764	77.2
	Ciprofloxacin	1,734	71.0
	Gentamicin	1,858	77.2
	Levofloxacin	1,475	68.0
	Ofloxacin	199	44.7
	Piperacillin-tazobactam	1,484	91.0
	Tobramycin	1,708	87.5

^aCoNS, coagulase-negative staphylococci

Back to article page

ISSN: 1476-0711

Contact us

Submission enquiries: journalsubmissions@springernature.com